tau degraders (APRINOIA Therapeutics)

N/A

Report date: 2025/03/20 09:14:59
NME

Base Information

Drug Nametau degraders (APRINOIA Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases modulators
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsNerve DegenerationFrontotemporal DementiaAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAprinoia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAprinoia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationFrontotemporal DementiaAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A